IRegained Inc.

Key People

• Vineet Johnson - Founder, President & CEO
• Samir Sahoo - Chief Operating Officer
• Ranjit Stanley - Co-Founder and Chief Scientific Officer
• Michael Dolinar - Chief Technology Officer

Assessment

Team

Aspect: First-time 10+ yrs
Summary: The leadership team comprises experienced professionals with significant expertise in their respective fields.

The leadership team includes individuals with extensive experience in medical technology and business operations, which is crucial for navigating the complexities of the MedTech industry.

Clinical Need

Aspect: Very Strong
Summary: The MyHand System addresses a significant unmet need in stroke rehabilitation.

With millions of stroke survivors experiencing hand function impairment, the MyHand System's targeted approach offers a valuable solution to a widespread problem.

Competition

Aspect: Somewhat crowded
Summary: The stroke rehabilitation market has several players, but IRegained's approach offers differentiation.

Competitors like Saebo and Tyromotion offer rehabilitation devices, but IRegained's focus on neuroplasticity and gamification sets it apart.

Technical Challenge

Aspect: Moderate
Summary: Developing a device that effectively leverages neuroplasticity presents moderate technical challenges.

The integration of neuroscience principles with user-friendly technology requires careful design and testing but is achievable with current technological capabilities.

Patent

Aspect: Strong
Summary: IRegained has secured patents for its MyHand System, providing a competitive advantage.

Patents protect the unique aspects of the MyHand System, preventing competitors from replicating its innovative features.

Financing

Aspect: Medium
Summary: IRegained has secured funding from various investors, supporting its growth and development.

The company has raised funds from angel investors and investment funds, but further financing will be essential for large-scale commercialization.

Regulatory

Aspect: 510k/PMA
Summary: The MyHand System has received FDA approval, facilitating its entry into the U.S. market.

Achieving FDA approval indicates compliance with stringent safety and efficacy standards, which is crucial for market acceptance.

Opportunity Rollup

Odds of Success

3.85

Peak Market Share

5.2

Segment CAGR

9.2%

Market Segment

Stroke Rehabilitation Devices

Market Sub Segment

Hand Function Rehabilitation

Key Takeaway

IRegained's MyHand System addresses a critical need in stroke rehabilitation with innovative technology, positioning the company for significant growth in a competitive market.